Article ; Online: A Highly Potent SARS-CoV-2 Blocking Lectin Protein.
ACS infectious diseases
2022 Volume 8, Issue 7, Page(s) 1253–1264
Abstract: The COVID-19 (coronavirus disease-19) pandemic affected more than 180 million people around the globe, causing more than five million deaths as of January 2022. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the new coronavirus, has been ... ...
Abstract | The COVID-19 (coronavirus disease-19) pandemic affected more than 180 million people around the globe, causing more than five million deaths as of January 2022. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the new coronavirus, has been identified as the primary cause of the infection. The number of vaccinated people is increasing; however, prophylactic drugs are highly demanded to ensure secure social contact. A number of drug molecules have been repurposed to fight against SARS-CoV-2, and some of them have been proven to be effective in preventing hospitalization or ICU admissions. Here, we demonstrated griffithsin (GRFT), a lectin protein, to block the entry of SARS-CoV-2 and its variants, Delta and Omicron, into the Vero E6 cell lines and IFNAR |
---|---|
MeSH term(s) | Animals ; COVID-19/drug therapy ; COVID-19/prevention & control ; Humans ; Lectins ; Mice ; Pandemics ; SARS-CoV-2 |
Chemical Substances | Lectins |
Language | English |
Publishing date | 2022-04-15 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ISSN | 2373-8227 |
ISSN (online) | 2373-8227 |
DOI | 10.1021/acsinfecdis.2c00006 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.